Resultats de la cerca - Anagnostou, Valsamo

Primary parotid adenocarcinoma metastasis to the spleen with PIK3CA mutation: cytological findings and review of the literature per Inouye, Casey M, Anagnostou, Valsamo, Li, Qing Kay

Obtenir text complet Obtenir text complet

Modeling Prognostic Factors in Resectable Pancreatic Adenocarcinomas per Botsis, Taxiarchis, Anagnostou, Valsamo K., Hartvigsen, Gunnar, Hripcsak, George, Weng, Chunhua

Obtenir text complet Obtenir text complet

Developing a Multivariable Prognostic Model for Pancreatic Endocrine Tumors Using the Clinical Data Warehouse Resources of a Single Institution per Botsis, Taxiarchis, Anagnostou, Valsamo K., Hartvigsen, Gunnar, Hripcsak, George, Weng, Chunhua

Obtenir text complet Obtenir text complet Obtenir text complet

Standardization of Epidermal Growth Factor Receptor (EGFR) Measurement by Quantitative Immunofluorescence and Impact on Antibody-Based Mutation Detection in Non–Small Cell Lung Can... per Dimou, Anastasios, Agarwal, Seema, Anagnostou, Valsamo, Viray, Hollis, Christensen, Stephen, Gould Rothberg, Bonnie, Zolota, Vassiliki, Syrigos, Konstantinos, Rimm, David L.

Obtenir text complet Obtenir text complet Obtenir text complet

Antibody validation per Bordeaux, Jennifer, Welsh, Allison W., Agarwal, Seema, Killiam, Elizabeth, Baquero, Maria T., Hanna, Jason A., Anagnostou, Valsamo K., Rimm, David L.

Obtenir text complet Obtenir text complet Obtenir text complet

Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity per Anagnostou, Valsamo, Yarchoan, Mark, Hansen, Aaron R., Wang, Hao, Verde, Franco, Sharon, Elad, Collyar, Deborah, Chow, Laura Q.M., Forde, Patrick M.

Obtenir text complet Obtenir text complet Obtenir text complet

Analytic Variability in Immunohistochemistry Biomarker Studies per Anagnostou, Valsamo K., Welsh, Allison W., Giltnane, Jennifer M., Siddiqui, Summar, Liceaga, Camil, Gustavson, Mark, Syrigos, Konstantinos N., Reiter, Jill L., Rimm, David L.

Obtenir text complet Obtenir text complet Obtenir text complet

Multi-Level Targeting of the Phosphatidylinositol-3-Kinase Pathway in Non-Small Cell Lung Cancer Cells per Zito, Christopher R., Jilaveanu, Lucia B., Anagnostou, Valsamo, Rimm, David, Bepler, Gerold, Maira, Sauveur-Michel, Hackl, Wolfgang, Camp, Robert, Kluger, Harriet M., Chao, Herta H.

Obtenir text complet Obtenir text complet Obtenir text complet

Quantitative Assessment of Effect of Preanalytic Cold Ischemic Time on Protein Expression in Breast Cancer Tissues per Neumeister, Veronique M., Anagnostou, Valsamo, Siddiqui, Summar, England, Allison Michal, Zarrella, Elizabeth R., Vassilakopoulou, Maria, Parisi, Fabio, Kluger, Yuval, Hicks, David G., Rimm, David L.

Obtenir text complet Obtenir text complet Obtenir text complet

Differential sensitivity to platinum-based chemotherapy in primary uterine serous papillary carcinoma cell lines with high versus low HER-2/neu expression in vitro per Cross, Sarah N., Cocco, Emiliano, Bellone, Stefania, Anagnostou, Valsamo K., Brower, Stacey L., Richter, Christine E., Siegel, Eric R., Schwartz, Peter E., Rutherford, Thomas J., Santin, Alessandro D.

Obtenir text complet Obtenir text complet Obtenir text complet

Programmed death ligand-1 expression in non-small cell lung cancer per Velcheti, Vamsidhar, Schalper, Kurt A, Carvajal, Daniel E, Rimm, David L, Anagnostou, Valsamo K, Syrigos, Konstantinos N, Sznol, Mario, Herbst, Roy S, Gettinger, Scott N, Chen, Lieping, Syrigos, Konstantinos N

Obtenir text complet Obtenir text complet Obtenir text complet

Artificial intelligence-assisted serial analysis of clinical cancer genomics data identifies changing treatment recommendations and therapeutic targets per Fischer, Catherine G., Pallavajjala, Aparna, Jiang, LiQun, Anagnostou, Valsamo, Tao, Jessica, Adams, Emily, Eshleman, James R., Gocke, Christopher D., Lin, Ming-Tseh, Platz, Elizabeth A., Xian, Rena R.

Obtenir text complet Obtenir text complet Obtenir text complet

Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: a Randomized Phase II Study per Osborne, C. Kent, Neven, Patrick, Dirix, Luc Y., Mackey, John R., Robert, Jean, Underhill, Craig, Schiff, Rachel, Gutierrez, Carolina, Migliaccio, Ilenia, Anagnostou, Valsamo K., Rimm, David L., Magill, Patrick, Sellers, Mark

Obtenir text complet Obtenir text complet Obtenir text complet

A Tissue Quality Index – an Intrinsic Control for Measurement of Effects of Pre-analytical Variables on FFPE Tissue per Neumeister, Veronique M., Parisi, Fabio, England, Allison M., Siddiqui, Summar, Anagnostou, Valsamo, Zarrella, Elizabeth, Vassilakopolou, Maria, Bai, Yalai, Saylor, Sasha, Sapino, Anna, Kluger, Yuval, Hicks, David G., Bussolati, Gianni, Kwei, Stephanie, Rimm, David L.

Obtenir text complet Obtenir text complet Obtenir text complet

High-throughput prediction of MHC class I and class II neoantigens with MHCnuggets per Shao, Xiaoshan M., Bhattacharya, Rohit, Huang, Justin, Sivakumar, I.K. Ashok, Tokheim, Collin, Zheng, Lily, Hirsch, Dylan, Kaminow, Benjamin, Omdahl, Ashton, Bonsack, Maria, Riemer, Angelika B., Velculescu, Victor E., Anagnostou, Valsamo, Pagel, Kymberleigh A., Karchin, Rachel

Obtenir text complet Obtenir text complet Obtenir text complet

High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology per Anagnostou, Valsamo K, Lowery, Frank J, Zolota, Vassiliki, Tzelepi, Vassiliki, Gopinath, Arun, Liceaga, Camil, Panagopoulos, Nikolaos, Frangia, Konstantina, Tanoue, Lynn, Boffa, Daniel, Gettinger, Scott, Detterbeck, Frank, Homer, Robert J, Dougenis, Dimitrios, Rimm, David L, Syrigos, Konstantinos N

Obtenir text complet Obtenir text complet Obtenir text complet

Personalized genomic analyses for cancer mutation discovery and interpretation per Jones, Siân, Anagnostou, Valsamo, Lytle, Karli, Parpart-Li, Sonya, Nesselbush, Monica, Riley, David R., Shukla, Manish, Chesnick, Bryan, Kadan, Maura, Papp, Eniko, Galens, Kevin G., Murphy, Derek, Zhang, Theresa, Kann, Lisa, Sausen, Mark, Angiuoli, Samuel V., Diaz, Luis A., Velculescu, Victor E.

Obtenir text complet Obtenir text complet Obtenir text complet

GOLPH3 modulates mTOR signaling and rapamycin sensitivity in cancer per Scott, Kenneth L., Kabbarah, Omar, Liang, Mei-Chih, Ivanova, Elena, Anagnostou, Valsamo, Wu, Joyce, Dhakal, Sabin, Wu, Min, Chen, Shujuan, Feinberg, Tamar, Huang, Joseph, Saci, Abdel, Widlund, Hans R., Fisher, David E., Xiao, Yonghong, Rimm, David L., Protopopov, Alexei, Wong, Kwok-Kin, Chin, Lynda

Obtenir text complet Obtenir text complet Obtenir text complet

A machine learning approach for somatic mutation discovery per Wood, Derrick E., White, James R., Georgiadis, Andrew, Van Emburgh, Beth, Parpart-Li, Sonya, Mitchell, Jason, Anagnostou, Valsamo, Niknafs, Noushin, Karchin, Rachel, Papp, Eniko, McCord, Christine, LoVerso, Peter, Riley, David, Diaz, Luis A., Jones, Siân, Sausen, Mark, Velculescu, Victor E., Angiuoli, Samuel V.

Obtenir text complet Obtenir text complet Obtenir text complet

Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma—a phase 3 randomised trial per Kok, Peey Sei, Forde, Patrick M, Hughes, Brett, Sun, Zhuoxin, Brown, Chris, Ramalingam, Suresh, Cook, Alistair, Lesterhuis, Willem Joost, Yip, Sonia, O’Byrne, Ken, Pavlakis, Nick, Brahmer, Julie, Anagnostou, Valsamo, Ford, Kate, Fitzpatrick, Karen, Bricker, Alison, Cummins, Michelle M, Stockler, Martin, Nowak, Anna K

Obtenir text complet Obtenir text complet Obtenir text complet